Please use this identifier to cite or link to this item: http://dspace.unimap.edu.my:80/xmlui/handle/123456789/13977
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHairul Nazirah, Abdul Halim-
dc.contributor.authorMohamed Zulkali, Mohamed Daud, Prof. Madya Dr.-
dc.contributor.authorZulfakar, Mokhtar-
dc.contributor.authorAkmal Hadi, Ma'Radzi-
dc.date.accessioned2011-10-03T06:27:26Z-
dc.date.available2011-10-03T06:27:26Z-
dc.date.issued2008-12-12-
dc.identifier.urihttp://dspace.unimap.edu.my/123456789/13977-
dc.descriptionInternational Conference on Science and Technology (ICSTIE 2008), Applications in Industry and Education (2008) organized by Universiti Teknologi MARA (UiTM), 12th - 13th December 2008 at Penang, Malaysia.en_US
dc.description.abstractThe development of single-enantiomer drug from racemate chiral drugs is a challenging field in pharmaceutical industries which has opened a new market strategy for pharmaceutical firms. In this review, two types of membrane-based approaches for separation of chiral drugs are highlighted which are Supported Liquid Membrane (SLM) and Enzymatic Membrane Reactor (EMR). The present overview attempts to cover the current review in separation of chiral drugs and some understanding of the advantages of using these methods.en_US
dc.language.isoenen_US
dc.publisherUniversiti Teknologi MARA (UiTM)en_US
dc.relation.ispartofseriesProceedings of the International Conference on Science and Technology (ICSTIE 2008), Applications in Industry and Education (2008)en_US
dc.subjectChiral drugsen_US
dc.subjectRacemic switchen_US
dc.subjectSupported Liquid Membrane (SLM)en_US
dc.subjectEnzymatic Membrane Reactor (EMR)en_US
dc.titleEnantiomer separation through membrane-based approaches: A reviewen_US
dc.typeWorking Paperen_US
dc.contributor.urlhairulnazirah@unimap.edu.myen_US
Appears in Collections:Conference Papers

Files in This Item:
File Description SizeFormat 
enentiomer.pdf6.88 kBAdobe PDFView/Open


Items in UniMAP Library Digital Repository are protected by copyright, with all rights reserved, unless otherwise indicated.